<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-04-17T17:32:14Z</responseDate><request verb="GetRecord" identifier="oai:www.recercat.cat:10459.1/57161" metadataPrefix="didl">https://recercat.cat/oai/request</request><GetRecord><record><header><identifier>oai:recercat.cat:10459.1/57161</identifier><datestamp>2024-12-05T21:21:13Z</datestamp><setSpec>com_2072_3622</setSpec><setSpec>col_2072_479130</setSpec></header><metadata><d:DIDL xmlns:d="urn:mpeg:mpeg21:2002:02-DIDL-NS" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="urn:mpeg:mpeg21:2002:02-DIDL-NS http://standards.iso.org/ittf/PubliclyAvailableStandards/MPEG-21_schema_files/did/didl.xsd">
   <d:DIDLInfo>
      <dcterms:created xmlns:dcterms="http://purl.org/dc/terms/" xsi:schemaLocation="http://purl.org/dc/terms/ http://dublincore.org/schemas/xmls/qdc/dcterms.xsd">2024-12-05T21:21:13Z</dcterms:created>
   </d:DIDLInfo>
   <d:Item id="hdl_10459.1_57161">
      <d:Descriptor>
         <d:Statement mimeType="application/xml; charset=utf-8">
            <dii:Identifier xmlns:dii="urn:mpeg:mpeg21:2002:01-DII-NS" xsi:schemaLocation="urn:mpeg:mpeg21:2002:01-DII-NS http://standards.iso.org/ittf/PubliclyAvailableStandards/MPEG-21_schema_files/dii/dii.xsd">urn:hdl:10459.1/57161</dii:Identifier>
         </d:Statement>
      </d:Descriptor>
      <d:Descriptor>
         <d:Statement mimeType="application/xml; charset=utf-8">
            <oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
               <dc:title>Proteomic and oxidative stress analysis in human brain samples of Huntington disease</dc:title>
               <dc:creator>Sorolla Bardají, Maria Alba</dc:creator>
               <dc:creator>Reverter Branchat, Gemma</dc:creator>
               <dc:creator>Tamarit Sumalla, Jordi</dc:creator>
               <dc:creator>Ferrer, Isidre</dc:creator>
               <dc:creator>Ros Salvador, Joaquim</dc:creator>
               <dc:creator>Cabiscol Català, Elisa</dc:creator>
               <dc:subject>Huntington disease</dc:subject>
               <dc:subject>Proteomic analysis</dc:subject>
               <dc:subject>Oxidative stress</dc:subject>
               <dc:subject>Protein carbonylation</dc:subject>
               <dc:description>Huntington disease (HD) is a neurodegenerative disorder caused by expansion of CAG repeats in exon 1 of the&#xd;
huntingtin gene, affecting initially the striatum and progressively the cortex. This work reports a proteomic&#xd;
analysis of human brain postmortem samples obtained from striatum and cortex of patients with HD&#xd;
compared to samples of age- and sex-matched controls. Antioxidant defense proteins that were strongly&#xd;
induced in striatum, but also detectable in cortex, were identified as peroxiredoxins 1, 2, and 6, as well as&#xd;
glutathione peroxidases 1 and 6. The activities of other antioxidant enzymes such as mitochondrial&#xd;
superoxide dismutase and catalase were also increased in HD. Aconitase, a protein involved in energy&#xd;
metabolism, showed decreased activities in striatum of HD patients. Protein carbonyls, used as markers of&#xd;
oxidative stress, were increased in HD, and glial fibrillary acidic protein, aconitase, γ-enolase, and creatine&#xd;
kinase B were identified as the main targets. Taken together, these results indicate that oxidative stress and&#xd;
damage to specific macromolecules would participate in the disease progression. Also, these data support the&#xd;
rationale for therapeutic strategies that either potentiate antioxidant defenses or avoid oxidative stress&#xd;
generation to delay disease progression.</dc:description>
               <dc:description>This work has been supported by Grants BFU2004-00593/BMC, BFU2007-66249, and CSD2007-20 Consolider Ingenio 2010 from the Ministerio de Educación y Ciencia (Spain) and SGR2005-00677 from the Generalitat de Catalunya. M. A. Sorolla is the recipient of a Ph.D. fellowship from the Ministerio de Educación y Ciencia (Spain)</dc:description>
               <dc:date>2024-12-05T21:21:13Z</dc:date>
               <dc:date>2024-12-05T21:21:13Z</dc:date>
               <dc:date>2016-06-06T10:32:52Z</dc:date>
               <dc:date>2025-01-01</dc:date>
               <dc:date>2008</dc:date>
               <dc:type>article</dc:type>
               <dc:type>publishedVersion</dc:type>
               <dc:identifier>http://hdl.handle.net/10459.1/57161</dc:identifier>
               <dc:relation>MIECI/PN2004-2007/BFU2004-00593/BMC</dc:relation>
               <dc:relation>MIECI/PN2004-2007/BFU2007-66249</dc:relation>
               <dc:relation>Reproducció del document publicat a https://doi.org/10.1016/j.freeradbiomed.2008.05.014</dc:relation>
               <dc:relation>Free Radical Biology and Medicine, 2008, vol. 45, núm. 5, p. 667-678</dc:relation>
               <dc:rights>(c) Elsevier Inc., 2008</dc:rights>
               <dc:rights>info:eu-repo/semantics/restrictedAccess</dc:rights>
               <dc:publisher>Elsevier</dc:publisher>
            </oai_dc:dc>
         </d:Statement>
      </d:Descriptor>
   </d:Item>
</d:DIDL></metadata></record></GetRecord></OAI-PMH>